Carbazole-containing arylcarboxamides as BACE1 inhibitors

被引：25

作者：

Bertini, Simone ^{[1
]}

Asso, Valentina ^{[1
]}

Ghilardi, Elisa ^{[1
]}

Granchi, Carlotta ^{[1
]}

Manera, Clementina ^{[1
]}

Minutolo, Filippo ^{[1
]}

Saccomanni, Giuseppe ^{[1
]}

Bortolato, Andrea ^{[2
]}

Mason, Jonathan ^{[2
,4
]}

Moro, Stefano ^{[3
]}

Macchia, Marco ^{[1
]}

机构：

[1] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy

[2] Heptares Therapeut Ltd, Welwyn Garden City AL7 RAX, Herts, England

[3] Univ Padua, Dipartimento Sci Farmaceut, Mol Modeling Sect, I-35131 Padua, Italy

[4] Lundbeck AS, DK-2500 Copenhagen, Denmark

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 22期

关键词：

Alzheimer; BACE1; Carbazole; Molecular docking; Flap; AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; DESIGN; MODEL; SITE; MATURATION; PREDICTION; DOCKING;

D O I：

10.1016/j.bmcl.2011.09.064

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

beta-Secretase (BACE1) is widely recognized as a prime drug target for the treatment of Alzheimer's disease (AD). In this Letter, we report the synthesis and the BACE1 inhibitory activity of novel, variously substituted N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-arylcarboxamides. The best results have been obtained with the introduction of a 4-OMe substituent (IC50 = 3.8 mu M) or a 3,4-dichloro substituent (IC50 = 2.5 mu M) in the amidic aromatic ring. The blood-brain barrier penetration predictions resulted to be promising for this type of compounds. To better understand the structure-activity relationships (SAR) of the new derivatives, a docking study procedure has been applied exploiting different conformational and ionic states of BACE1. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：6657 / 6661

页数：5

共 50 条

[41] BACE1 inhibitors: A head group scan on a series of amides
Woltering, Thomas J.
Wostl, Wolfgang
Hilpert, Hans
Rogers-Evans, Mark
Pinard, Emmanuel
Mayweg, Alexander
Goebel, Martin
Banner, David W.
Benz, Joerg
Travagli, Massimiliano
Pollastrini, Martina
Marconi, Guido
Gabellieri, Emanuele
Guba, Wolfgang
Mauser, Harald
Andreini, Matteo
Jacobsen, Helmut
Power, Eoin
Narquizian, Robert
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4239 - 4243
[42] Influence of functional moiety in lupane-type triterpenoids in BACE1 inhibition
Wagle, Aditi
Seong, Su Hui
Julia Castro, Maria
Belen Faraoni, Maria
Murray, Ana Paula
Jun, Hyun Ah
Choi, Jae Sue
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 83
[43] Evaluation of superior BACE1 cleavage sequences containing unnatural amino acids
Kakizawa, Taeko
Sanjoh, Akira
Kobayashi, Akane
Hattori, Yasunao
Teruya, Kenta
Akaji, Kenichi
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (09) : 2785 - 2789
[44] Preparation and biological evaluation of conformationally constrained BACE1 inhibitors
Winneroski, Leonard L.
Schiffler, Matthew A.
Erickson, Jon A.
May, Patrick C.
Monk, Scott A.
Timm, David E.
Audia, James E.
Beck, James P.
Boggs, Leonard N.
Borders, Anthony R.
Boyer, Robert D.
Brier, Richard A.
Hudziak, Kevin J.
Klimkowski, Valentine J.
Losada, Pablo Garcia
Mathes, Brian M.
Stout, Stephanie L.
Watson, Brian M.
Mergott, Dustin J.
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 3260 - 3268
[45] Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position
Hamada, Yoshio
Nakanishi, Tomoya
Suzuki, Kenji
Yamaguchi, Ryoji
Hamada, Takashi
Hidaka, Koushi
Ishiura, Shoichi
Kiso, Yoshiaki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4640 - 4644
[46] Fragment-based discovery and optimization of BACE1 inhibitors
Madden, James
Dod, Jenny R.
Godemann, Robert
Kraemer, Joachim
Smith, Myron
Biniszkiewicz, Marion
Hallett, David J.
Barker, John
Dyekjaer, Jane D.
Hesterkamp, Thomas
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5329 - 5333
[47] BACE1 in Alzheimer's disease
Sathya, M.
Premkumar, P.
Karthick, C.
Moorthi, P.
Jayachandran, K. S.
Anusuyadevi, M.
CLINICA CHIMICA ACTA, 2012, 414 : 171 - 178
[48] Flavonoid and Chalcone Scaffolds as Inhibitors of BACE1: Recent Updates
Narayanan, Anishma Payyappilliparambil
Jayan, Jayalakshmi
Sudevan, Sachithra Thazhathuveedu
Dhyani, Archana
Zachariah, Subin Mary
Mathew, Bijo
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (09) : 1243 - 1256
[49] Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer's disease
Mukerjee, Nobendu
Das, Anubhab
Jawarkar, Rahul D.
Maitra, Swastika
Das, Padmashree
Castrosanto, Melvin A.
Paul, Soumyadip
Samad, Abdul
Zaki, Magdi E. A.
Al-Hussain, Sami A.
Masand, Vijay H.
Hasan, Mohammad Mehedi
Bukhari, Syed Nasir Abbas
Perveen, Asma
Alghamdi, Badrah S.
Alexiou, Athanasios
Kamal, Mohammad Amjad
Dey, Abhijit
Malik, Sumira
Bakal, Ravindra L.
Abuzenadah, Adel Mohammad
Ghosh, Arabinda
Md Ashraf, Ghulam
FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
[50] Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of β-secretase (BACE1)
Huber, Timo
Manzenrieder, Florian
Kuttruff, Christian A.
Dorner-Ciossek, Cornelia
Kessler, Horst
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4427 - 4431

← 1 2 3 4 5 →